Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,926 | 996 | 59.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,450 | 6 | 35.5% |
| Travel and Lodging | $1,703 | 4 | 4.9% |
| Education | $31.66 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $15,700 | 46 | $0 (2021) |
| Novo Nordisk Inc | $3,543 | 171 | $0 (2024) |
| ABBVIE INC. | $2,194 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,139 | 93 | $0 (2024) |
| Lilly USA, LLC | $1,323 | 73 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,186 | 51 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $972.44 | 47 | $0 (2024) |
| Allergan, Inc. | $753.43 | 40 | $0 (2021) |
| PFIZER INC. | $671.12 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $540.25 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,672 | 122 | AstraZeneca Pharmaceuticals LP ($462.55) |
| 2023 | $3,383 | 154 | AbbVie Inc. ($705.93) |
| 2022 | $3,131 | 159 | ABBVIE INC. ($673.55) |
| 2021 | $2,285 | 99 | Novo Nordisk Inc ($584.74) |
| 2020 | $1,971 | 108 | Novo Nordisk Inc ($417.45) |
| 2019 | $1,941 | 120 | Novo Nordisk Inc ($475.28) |
| 2018 | $7,352 | 114 | Janssen Pharmaceuticals, Inc ($5,562) |
| 2017 | $12,376 | 134 | Janssen Pharmaceuticals, Inc ($10,008) |
All Payment Transactions
1,010 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Biological | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.98 | General |
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Obesity | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,482 | 5,961 | $982,925 | $498,632 |
| 2022 | 26 | 2,436 | 5,817 | $994,472 | $479,010 |
| 2021 | 27 | 2,592 | 6,096 | $955,625 | $480,462 |
| 2020 | 26 | 2,726 | 5,876 | $896,377 | $416,268 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 229 | 780 | $170,749 | $56,111 | 32.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 281 | 500 | $50,224 | $38,490 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 367 | $40,275 | $30,205 | 75.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 180 | 180 | $28,061 | $28,095 | 100.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 157 | 344 | $77,138 | $28,015 | 36.3% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 182 | 185 | $55,500 | $27,878 | 50.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 269 | $32,331 | $25,717 | 79.5% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 20 | 146 | $30,485 | $23,188 | 76.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 122 | 131 | $26,200 | $12,411 | 47.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 41 | $9,582 | $7,488 | 78.1% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2022 | 18 | 65 | $6,586 | $5,115 | 77.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 16 | 42 | $12,600 | $3,912 | 31.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 27 | 35 | $4,311 | $3,435 | 79.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 13 | 13 | $39,000 | $3,164 | 8.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 12 | 52 | $2,692 | $2,040 | 75.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 37 | 56 | $1,785 | $1,791 | 100.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 27 | $1,878 | $1,412 | 75.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 35 | 35 | $794.15 | $797.30 | 100.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 34 | 34 | $756.84 | $759.89 | 100.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 180 | 221 | $5,525 | $654.87 | 11.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 43 | 47 | $1,880 | $638.32 | 34.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 42 | $724.50 | $565.05 | 78.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $325.00 | $322.75 | 99.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 13 | $195.00 | $124.80 | 64.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 18 | 32 | $800.00 | $43.36 | 5.4% |
About Dr. Miguel Tirado, M.D
Dr. Miguel Tirado, M.D is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922072313.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miguel Tirado, M.D has received a total of $35,111 in payments from pharmaceutical and medical device companies, with $2,672 received in 2024. These payments were reported across 1,010 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($20,926).
As a Medicare-enrolled provider, Tirado has provided services to 10,236 Medicare beneficiaries, totaling 23,750 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Addiction Medicine
- Location Staten Island, NY
- Active Since 02/14/2006
- Last Updated 08/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922072313
Products in Payments
- XARELTO (Drug) $15,447
- VRAYLAR (Drug) $1,195
- FARXIGA (Drug) $1,109
- Ozempic (Drug) $1,108
- Kerendia (Drug) $972.44
- UBRELVY (Drug) $866.87
- Victoza (Drug) $809.15
- TRULICITY (Drug) $756.98
- TRELEGY ELLIPTA (Drug) $534.10
- XIFAXAN (Drug) $485.95
- QULIPTA (Drug) $473.99
- REXULTI (Drug) $415.38
- Rybelsus (Drug) $411.40
- SYMBICORT (Drug) $353.41
- BREZTRI (Drug) $349.99
- TRINTELLIX (Drug) $340.96
- Saxenda (Drug) $336.74
- JANUVIA (Drug) $326.30
- Tresiba (Drug) $307.23
- NURTEC ODT (Drug) $306.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Dr. Alan Dunton, M.d, M.D
Internal Medicine — Payments: $34,946
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178
Dr. Efat Azizi, M.d, M.D
Internal Medicine — Payments: $28,427